Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37487981)
Watch
English
Novel chemotherapy approaches for cervical cancer.
scientific article published on July 2009
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Novel chemotherapy approaches for cervical cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
cervix uterine cancer
1 reference
based on heuristic
inferred from title
author
Hugo Arias-Pulido
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
Claire F. Verschraegen
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
author name string
Sujana Movva
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
Lorna Rodriguez
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
language of work or name
English
0 references
publication date
1 July 2009
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
volume
115
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
issue
14
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
page(s)
3166-3180
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
cites work
Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
21 January 2018
The causal relation between human papillomavirus and cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
21 January 2018
Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
21 January 2018
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer statistics, 2006
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemoradiation and adjuvant chemotherapy in cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nephrotoxicity following Single Dose Mithramycin Therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized Trial of Neoadjuvant Cisplatin, Vincristine, Bleomycin, and Radical Hysterectomy Versus Radiation Therapy for Bulky Stage IB and IIA Cervical Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact on survival following successful neoadjuvant chemotherapy and radical surgery for Stage IIb bulky and Stage IIIb cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of metastatic cervical cancer: review of the literature
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cancer cervix: initial results of an IAEA multicentre randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Examination of the pRb-dependent and pRb-independent functions of E7 in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic value of epidermal growth factor receptor expression in cervical carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EGFR and cancer prognosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcriptional regulation of the EGF receptor promoter by HPV16 and retinoic acid in human ectocervical epithelial cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Absence of epidermal growth factor receptor mutations in cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The viral etiology of cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Eastern Cooperative Oncology Group study E1E96.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ERBB receptors and cancer: the complexity of targeted inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The epidermal growth factor receptor pathway: a model for targeted therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EGF-ERBB signalling: towards the systems level
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The tumour microenvironment as a target for chemoprevention.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pemetrexed (Alimta, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: a Southwest Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.24364
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/CNCR.24364
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
PubMed publication ID
19452541
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19452541
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19452541%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
ResearchGate publication ID
24437319
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit